$ATHA Athira Pharma, Inc. Insider Trading
Get free email notifications about insider trading in Athira Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Athira Pharma, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Athira Pharma, Inc. for free.
CIK Number: 0001620463
IRS Number: 453368487
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ATHA
Company Address: 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL 98011
Phone number: 5095927191
Former name: M3 Biotechnology, Inc., date of change: 2014-09-24
Athira Pharma, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 01 2021 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 19.94 | 13,871 | 276,588 | 13,871 | |
Jun 01 2021 | ATHA | Athira Pharma, Inc ... | EDELMAN JOSEPH | Director | Option Exercise | A | 19.94 | 13,871 | 276,588 | 13,871 | |
Mar 08 2021 | ATHA | Athira Pharma, Inc ... | Kosacz Barbara | Director | Option Exercise | A | 19.29 | 27,742 | 535,143 | 27,742 | |
Feb 22 2021 | ATHA | Athira Pharma, Inc ... | MOEBIUS HANS | Chief Medical Offic ... | Option Exercise | A | 21.15 | 72,000 | 1,522,800 | 72,000 | |
Feb 22 2021 | ATHA | Athira Pharma, Inc ... | MILESON GLENNA | Chief Financial Off ... | Option Exercise | A | 21.15 | 73,500 | 1,554,525 | 73,500 | |
Feb 22 2021 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | A | 21.15 | 85,000 | 1,797,750 | 85,000 | |
Feb 22 2021 | ATHA | Athira Pharma, Inc ... | KAWAS LEEN | President & CEO | Option Exercise | A | 21.15 | 231,000 | 4,885,650 | 231,000 | |
Feb 22 2021 | ATHA | Athira Pharma, Inc ... | CHURCH KEVIN | Vice President of D ... | Option Exercise | A | 21.15 | 20,000 | 423,000 | 20,000 | |
Feb 04 2021 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Option Exercise | M | 1.35 | 3,783 | 5,107 | 0 | |
Feb 04 2021 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Option Exercise | M | 1.19 | 25,220 | 30,012 | 0 | |
Feb 04 2021 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Buy | M | 1.35 | 3,783 | 5,107 | 143,884 | 140.1 K to 143.9 K (+2.70 %) |
Feb 04 2021 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Buy | M | 1.19 | 25,220 | 30,012 | 140,101 | 114.9 K to 140.1 K (+21.95 %) |
Jan 27 2021 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 22.50 | 311,111 | 6,999,998 | 3,425,916 | 3.1 M to 3.4 M (+9.99 %) |
Dec 14 2020 | ATHA | Athira Pharma, Inc ... | Romano Kelly A | Director | Option Exercise | A | 29.41 | 27,742 | 815,892 | 27,742 | |
Sep 22 2020 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 1,644,785 | 0 | 0 |